Loss-of-function mutations in the human gene SCN9A encoding the Nav1.7 α subunit result in a congenital inability to experience pain [13,14], while gain-of-function mutations in SCN9A lead to inherited erythromelalgia [15] and paroxysmal extreme pain disorder [16]. The gene discussed is SCN9A; the disease is erythromelalgia.